Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has led to widespread use of hydroxychloroquine and azithromycin despite the lack of conclusive evidence for their safety and efficacy. We evaluated the association between treatment with hydroxychloroquine and/or azithromycin...
Main Authors: | Filippo Albani, Federica Fusina, Alessia Giovannini, Pierluigi Ferretti, Anna Granato, Chiara Prezioso, Danilo Divizia, Alessandra Sabaini, Marco Marri, Elena Malpetti, Giuseppe Natalini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/9/2800 |
Similar Items
-
CLINICAL OUTCOMES AND ADVERSE DRUG REACTIONS IN COVID-19 PATIENTS TREATED WITH HYDROXYCHLOROQUINE AND AZITHROMYCIN ALONE OR COMBINED
by: H. Rathi, et al.
Published: (2021-11-01) -
Hydroxychloroquine, azithromycin and methylprednisolone and in hospital survival in severe COVID-19 pneumonia
by: Ronaldo C. Go, et al.
Published: (2022-09-01) -
Proarrhythmia assessment in treatment with hydroxychloroquine and azithromycin hospitalized elderly COVID-19 patients - our experience
by: Raffaele Costa, et al.
Published: (2021-06-01) -
Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring
by: Archana Ramireddy, et al.
Published: (2020-06-01) -
Effect of hydroxychloroquine and azithromycin combination use in COVID-19 patients – An umbrella review
by: Kaushik Nag, et al.
Published: (2024-01-01)